Trial Profile
Prediction of portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates in liver cirrhosis with portal hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Antithrombin III (Primary) ; Danaparoid sodium; Warfarin
- Indications Hepatic venous thrombosis
- Focus Therapeutic Use
- 12 Mar 2014 New trial record